Hi, Jun Tomioka here.
According to Nikkei Newspaper, Fujirebio Inc. which is
a Japanese medical company, announced that they developed
test reagent to check Alzheimer’s-type dementia.
If the reagent will be used easily, patients can start
medical treatment quickly.
Patients of dementia are 550 billion in the world as of 2021
and they are increasing rapidly.
It’s a very serious issue for human.
※コメント投稿者のブログIDはブログ作成者のみに通知されます